Bourque, M.; Grégoire, L.; Patel, W.; Dickens, D.; Snodgrass, R.; Di Paolo, T.
AV-101, a Pro-Drug Antagonist at the NMDA Receptor Glycine Site, Reduces L-Dopa Induced Dyskinesias in MPTP Monkeys. Cells 2022, 11, 3530.
https://doi.org/10.3390/cells11223530
AMA Style
Bourque M, Grégoire L, Patel W, Dickens D, Snodgrass R, Di Paolo T.
AV-101, a Pro-Drug Antagonist at the NMDA Receptor Glycine Site, Reduces L-Dopa Induced Dyskinesias in MPTP Monkeys. Cells. 2022; 11(22):3530.
https://doi.org/10.3390/cells11223530
Chicago/Turabian Style
Bourque, Mélanie, Laurent Grégoire, Waseema Patel, David Dickens, Ralph Snodgrass, and Thérèse Di Paolo.
2022. "AV-101, a Pro-Drug Antagonist at the NMDA Receptor Glycine Site, Reduces L-Dopa Induced Dyskinesias in MPTP Monkeys" Cells 11, no. 22: 3530.
https://doi.org/10.3390/cells11223530
APA Style
Bourque, M., Grégoire, L., Patel, W., Dickens, D., Snodgrass, R., & Di Paolo, T.
(2022). AV-101, a Pro-Drug Antagonist at the NMDA Receptor Glycine Site, Reduces L-Dopa Induced Dyskinesias in MPTP Monkeys. Cells, 11(22), 3530.
https://doi.org/10.3390/cells11223530